LONDON, Dec 10 () - Roche said on Wednesday its experimental oral drug giredestrant reduced the risk of breast cancer recurrence by ​30% compared with standard endocrine therapy, in what it said marked ‌the first big advance in hormonal treatment for the disease in over 20 years. The Swiss ‌drugmaker said detailed results from the phase III lidERA trial showed at three years, 92.

Venice has been charmed by a recent visitor: An acrobatic, wild dolphin. The dolphin nicknamed Mimmo has been delighting tourists and Venetians for months with his acrobatic flips. Experts are now eager to move him into open water, especially after verifying wounds indicating that the dolphin had been likely hit by a boat propeller.

When you think of Italian sports cars, your mind probably conjures up images of exotic shapes, symphony-like engine notes, and colors that make traffic lights jealous. But beyond the passion and artistry that Italy pours ... Read more